Showing 1551-1560 of 1970 results for "".
- Analysis: Millennials Drive Spending Growth in a Post-COVID Aesthetics Industryhttps://modernaesthetics.com/news/analysis-millennials-drive-spending-growth-in-a-post-covid-aesthetics-industry/2473413/The aesthetics industry is undergoing a swift transformation. Analysis of data from the last 5 years paints a clear picture of a post-pandemic shift in how the industry is addressing changing demand and the needs of a rapidly evolving customer base, according to market intelligence prov
- Evolus Acquires Exclusive US Distribution Rights to Evolysse Line of Dermal Fillershttps://modernaesthetics.com/news/evolus-acquires-exclusive-us-distribution-rights-to-evolysse-line-of-dermal-fillers/2473412/Evolus has entered into a definitive agreement to be the exclusive US distributor of a line of five dermal fillers currently in late-stage development. Evolus is partnering with Symatese, a privately held French company, to introduce the Evolysse line to its US customers beginning
- Study Shows Preventive Effects and Protective Potential of Astaxanthin on Collagen Damagehttps://modernaesthetics.com/news/study-shows-preventive-effects-and-protective-potential-of-astaxanthin-on-collagen-damage/2473411/A study recently found that Lycored's astaxanthin prevented against collagen damage from neutrophils, discovering its potential to protect collagen and enhance skin health. The study,
- MD360 Introduces Silkro RF Microneedling Platform with Plasmahttps://modernaesthetics.com/news/md360-introduces-silkro-rf-microneedling-platform-with-plasma/2473410/MD360 is rolling out the Silkro RF Microneedling Platform with Plasma. Developed with the South Korean Intelligent Design Team and Research and Developer HIRONIC, this platform includes four handpieces: Silk RF MN, Silkro Plasma, Silkro Smooth, Silkro Precision, and Silkro Gentle.
- Dr. Shiv Sabesan Named CTO at Cytrellishttps://modernaesthetics.com/news/dr-shiv-sabesan-named-cto-at-cytrellis/2473409/Dr. Shiv Sabesan is Cytrellis Biosystems’ Chief Technology Officer. In his new role, Dr. Sabesan will lead the company's strategy as it continues to advance its proprietary ellacor Micro-Coring technology and expand indications. The technology was
- Aquavit Files Investigational New Drug Application for Intradermal Dermatoxhttps://modernaesthetics.com/news/aquavit-files-investigational-new-drug-application-for-intradermal-dermatox/2473405/Aquavit has filed an Investigational New Drug Application with the U.S Food and Drug Administration (FDA) for Dermatox (aqubotulinumtoxinA), their intradermal injection of botulinum toxin. AqubotulinumtoxinA has already received regulatory approvals in Asia, Sou
- Sculptra Scores FDA Nod for Cheek Wrinkleshttps://modernaesthetics.com/news/sculptra-scores-fda-nod-for-cheeks/2473402/The U.S. Food and Drug Administration (FDA) has approved Sculptra (injectable poly-L-lactic acid (PLLA-SCA)) for the correction of fine lines and wrinkles in the cheek area. Sculptra is the first FDA-approved PLLA collagen stimulator that helps stimulate natural collagen produ
- Nadav Tomer is Cynosure’s New CEOhttps://modernaesthetics.com/news/nadav-tomer-is-cynosures-new-ceo/2473399/Nadav Tomer is Cynosure’s new chief executive officer, effective May 1, 2023. He succeeds Todd Tillemans, who will step down and will work closely with Mr. Tomer to ensure a smooth transition. "Nadav has an incredibly strong track record of operation
- Allergan Aesthetics Supports Women Surgeons with LIMITLESShttps://modernaesthetics.com/news/allergan-aesthetics-supports-women-surgeons-with-limitless/2473394/Allergan Aesthetics is launching LIMITLESS, an ongoing initiative in partnership with American Society of Plastic Surgeons (ASPS), The Aesthetic Society and the American Hernia Society. LIMITLESS was developed three years ago as a program to highlight women's achievements in p
- Plastic Surgeons Among Top Earners in 2022https://modernaesthetics.com/news/plastic-surgeons-among-top-earners-in-2023/2473393/The highest paid specialties in 2022 included plastic surgery ($619,000), orthopedics ($573,000), cardiology ($507,000) and urology ($506,000), according to the 2023 Medscape Physician Compensation Report. Dermatologists made about $443,000 in 2022. T